STENTiT selected as first participant in 2025 MedTech Innovator Accelerator!
During the MedTech Strategist Innovation Summit in Dublin, STENTiT was voted the #1 startup at the final pitch event of the MedTech Innovator Roadshow. The recognition places STENTiT as the first company selected to join the 2025 MedTech Innovator Accelerator — the world’s largest nonprofit accelerator dedicated to medical device, diagnostic, and digital health startups.
From a Global Pool to #1
STENTiT was one of 40 companies selected to pitch in Dublin, chosen from a global pool of over 1,400 applicants. Their selection as the top-ranked company reflects both the strength of their regenerative stent platform and their position as an emerging innovator in cardiovascular medical technology.
About the MedTech Innovator Accelerator
The MedTech Innovator Accelerator is a highly selective, four-month programme that supports early- to mid-stage startups in the medtech space. Each year, approximately 65 companies are selected from thousands of global applicants. Participants benefit from:
-
Tailored mentorship by industry experts
-
Connections to strategic investors and corporate partners
-
Access to major medtech events and exposure opportunities
-
Support with regulatory pathways and commercialization strategies
Upcoming Milestones
As part of the accelerator, STENTiT will participate in two key international gatherings:
-
MedTech Innovator Summit (June 2025) – Mountain View, California
-
The MedTech Conference (October 2025) – San Diego, United States
Both events offer strategic networking opportunities with investors, partners, and other selected startups.
About STENTiT
STENTiT, a Venture Challenge Fall 2016 alumnus, develops regenerative stents designed to restore natural vascular function. Their bioresorbable, tissue-regenerating implants represent a new approach to endovascular repair, with potential to transform long-term outcomes in cardiovascular intervention.
